Detection of vulnerable atherosclerotic plaque with near-infrared spectroscopy: a systematic review

Czech version

Authors: Cyril Štěchovský; Martin Horváth; Petr Hájek; Josef Veselka
Authors‘ workplace: Kardiologická klinika 2. LF UK a FN Motol Praha, přednosta prof. MUDr. Josef Veselka, CSc., FESC, FSCAI, FICA
Published in: Vnitř Lék 2014; 60(4): 375-379
Category: 60th Birthday - prof. MUDr. Petr Widimský, DrSc., FESC, FACC

Overview

The term vulnerable atherosclerotic plaque is used to describe an atherosclerotic lesion with a high probability of rupture and thrombosis causing an acute coronary event or stroke. Pathogenesis of the vulnerable plaque has been well described pathologically and on experimental models. Detection of vulnerable plaques in vivo has been limited so far. There has been lack of methods able to predict future event from certain lesion characteristics that were rigorously validated on prospective clinical trials. Intravascular near-infrared spectroscopy is a novel technique that has been intentionally developed for the identification of a lipid core within a plaque. Results from recent clinical trials seem promising. This review briefly summarizes current knowledge in the field of near-infrared spectroscopy.

Key words:
atherosclerosis – lipid core plaque – NIRS (near-infrared spectroscopy) – vulnerable plaque

Sources

1. Waksman R, Serruys PW. Handbook of the Vulnerable Plaque. Martin Dunitz: New York 2004. ISBN 9781841843230.

2. McDaniel MC, Eshtehardi P, Sawaya FJ et al. Contemporary clinical applications of coronary intravascular ultrasound. J Am Coll Cardiol Intv 2011; 4(11): 1155–1167.

3. Bezerra HG, Costa MA, Guagliumi G et al. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. J Am Coll Cardiol Intv 2009; 2(11): 1035–1046.

4. Stone GW, Maehara A, Lansky AJ et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364(3): 226–235.

5. Waxman S, Dixon SR, L'Allier P et al. In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques: Initial Results of the SPECTACL Study. JACC Cardiovasc Imaging 2009; 2(7):858–868.

6. Madder RD, Steinberg DH, Anderson RD. Multimodality Direct Coronary Imaging with Combined Near-Infrared Spectroscopy and Intravascular Ultrasound: Initial US Experience. Catheter Cardiovasc Interv 2013; 81(3): 551–557.

7. Madder RD, Goldstein JA, Madden SP et al. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Intv 2013; 6(8): 838–846.

8. Garcia BA, Wood F, Cipher D et al. Reproducibility of near-infrared spectroscopy for the detection of lipid core coronary plaques and observed changes after coronary stent implantation. Catheter Cardiovasc Interv 2010; 76(3): 359–365.

9. Goldstein JA, Maini B, Dixon SR et al. Detection of Lipid-core Plaques by Intra-coronary Near-infrared Spectroscopy Identifies High Risk of Peri-Procedural Myocardial Infarction. Circ Cardiovasc Interv 2011; 4(5): 429–437.

10. Dixon SR, Grines CL, Munir A et al. Analysis of Target Lesion Length Before Coronary Artery Stenting Using Angiography and Near-Infrared Spectroscopy Versus Angiography Alone. Am J Cardiol 2012; 109(1): 60–66.

11. Kini AS, Baber U, Kovacic JC et al. Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy: The YELLOW Trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy). J Am Coll Cardiol 2013; 62(1): 21–29.

12. Madder RD, Stone GW, Erlinge D et al. The Search for Vulnerable Plaque – The Pace Quickens. J Invasive Cardiol 2013; 25(Suppl A): 29–33.

13. Braunwald E. Epilogue: What do clinicians expect from imagers? J Am Coll Cardiol 2006; 47(Suppl 8): C101-C103.

14. Fleg JL, Stone GW, Fayad ZA et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012; 5(9): 941–955.